Prophylaxis of ERCP-related pancreatitis: A randomized, controlled trial of somatostatin and gabexate mesylate1 1The trial was designed and the manuscript was written by Dr. Andriulli. No pharmaceutical or private grants were searched for or made available for performing the present work.-Reference-Cited by-同舟云学术

Prophylaxis of ERCP-related pancreatitis: A randomized, controlled trial of somatostatin and gabexate mesylate1 1The trial was designed and the manuscript was written by Dr. Andriulli. No pharmaceutical or private grants were searched for or made available for performing the present work.

Published:2004-08 Issue:8 Volume:2 Page:713-718
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Andriulli Angelo,Solmi Luigi,Loperfido Silvano,Leo Pietro,Festa Virginia,Belmonte Angelo,Spirito Fulvio,Silla Michele,Forte Giovambattista,Terruzzi Vittorio,Marenco Giorgio,Ciliberto Enrico,Sabatino Antonio,Monica Fabio,Magnolia Maria Rita,Perri Francesco

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference23 articles.

1. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis;Andriulli;J Pancreas,2003

2. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography;Cavallini;N Engl J Med,1996

3. Prophylactic effect of somatostatin on post-ERCP pancreatitis;Poon;Gastrointest Endosc,1999

4. Medical treatment can prevent pancreatic injury after ERCP;Andriulli;Gastrointest Endosc,2000

5. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis;Andriulli;Gastrointest Endosc,2002

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of Somatostatin and Rectal Nonsteroidal Anti-Inflammatory Drugs for Prevention of Postendoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients: A Meta-Analysis of Randomized Controlled Trials;American Journal of Therapeutics;2024-09

2. ERCP後膵炎ガイドライン2023;Suizo;2024-04-30

3. Clinical Profiles and Outcomes of Patients Undergoing Endoscopic Retrograde Cholangiopancreatography in a Tertiary Care Center;Cureus;2024-02-27

4. Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis based on prospective, randomized, and controlled trials;Medicine;2023-10-13

5. Incidence, severity, and mortality of post-ERCP pancreatitis: an updated systematic review and meta-analysis of 145 randomized controlled trials;Gastrointestinal Endoscopy;2023-07